Shisui-machi, Japan

Masago Ishikawa


Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1999-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masago Ishikawa: Innovator in Pharmaceutical Chemistry

Introduction

Masago Ishikawa is a notable inventor based in Shisui-machi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating urinary disturbances. With a total of 2 patents to his name, Ishikawa's work is recognized for its potential therapeutic applications.

Latest Patents

Ishikawa's latest patents include a substituted piperidine derivative aimed at treating urinary disturbances. The first patent discloses a substituted piperidine derivative represented by a specific general formula. This compound exhibits excellent anticholinergic effects and calcium antagonism, which helps inhibit reflex bladder contraction. The second patent also focuses on a substituted piperidine derivative and a medicine comprising the same compound. This innovative approach is particularly useful for the prophylaxis and treatment of conditions such as pollakiuria.

Career Highlights

Masago Ishikawa is currently associated with Ss Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential to improve patient outcomes in urological health.

Collaborations

Ishikawa collaborates with talented coworkers, including Tomomi Okada and Fujiko Konno, who contribute to his research endeavors. Their combined expertise enhances the innovative capacity of their projects.

Conclusion

Masago Ishikawa stands out as a significant figure in pharmaceutical innovation, with his patents reflecting a commitment to addressing urinary disturbances through novel chemical compounds. His contributions are poised to make a meaningful impact in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…